Drug Induced Pulmonary Disease (DIPD) - PowerPoint PPT Presentation

1 / 12
About This Presentation
Title:

Drug Induced Pulmonary Disease (DIPD)

Description:

Drug Induced Pulmonary Disease (DIPD) John Noviasky, PharmD Background The number of medications linked to lung toxicity has doubled since 1972 Therapy related ... – PowerPoint PPT presentation

Number of Views:2265
Avg rating:3.0/5.0
Slides: 13
Provided by: JohnANo
Category:

less

Transcript and Presenter's Notes

Title: Drug Induced Pulmonary Disease (DIPD)


1
Drug Induced Pulmonary Disease (DIPD)
  • John Noviasky, PharmD

2
Background
  • The number of medications linked to lung toxicity
    has doubled since 1972
  • Therapy related pulmonary disease approaches 10
  • Multiple mechanisms
  • Related to Bradykinin (e.g.ACEI cough)
  • Antagonize normal airway tone maintenance (e.g. B
    Blockers)
  • Excess Leukotriene production (e.g. ASA)

3
Background
  • Multiple mechanisms
  • Increased capillary permeability (e.g.heroin)
  • IgE-mediated bronchospasm/anaphylaxis (e.g.
    cephalosporins)
  • Fluid Overload (e.g. Excess IV fluids)
  • Phospholipid storage disorder (e.g. Amiodarone)
  • Superoxide free radical (e.g. Paraquat)
  • Many unknown

4
Table 26-1Common
  • Bronchospasm
  • ACEI, Aspirin, B Blockers, Aerolized medications,
    NSAID, Sulfites
  • IgE-Mediated
  • Cephalosporin
  • Impairment of Respiratory Muscles
  • hypoventilation -Alcohol, narcotics, sedative
  • Neuromuscular Blockade- Aminoglycosides,
    Ca-Channel
  • Neuropathy - Amiodarone, captopril,

5
Table 26-1Common
  • Pulmonary Edema
  • Heroin, Methadone
  • IV fluids
  • Pulmonary Fibrosis
  • Amiodarone
  • Methysergide
  • Paraquat
  • Pulmonary Hypertension
  • Magnesium Trisilicate

6
Section 1
  • What points away from infectious process in CM?

7
Section 2
  • How many cases of pulmonary reactions from
    nitrofurantoin have been reported?
  • What is clinical course of acute pneumonitis?
  • How common is eosinophilia and ESR elevation in
    nitrofurantoin induced pneumonitis?
  • What is Loefflers Syndrome?

8
Section 3
  • How long should resolution of symptoms occur
    after withdrawal of offending agent?

9
Section 11
  • What is the most common presentation of
    amiodarone induced pulmonary toxicity?

10
Section 12
  • How often does amiodarone pulmonary toxicity
    (APT)occur in patients taking amiodarone?
  • How long has a patient usually been receiving
    amiodarone prior to APT? Usual dose?
  • Besides duration of therapy and dose, what are
    other risk factors for developing APT?

11
Section 13
  • What are 2 postulated mechanisms of Amiodarone
    pulmonary toxicity (APT)?

12
Section 14
  • How long after amiodarone is discontinued does
    APT usually reverse?
  • What is the half-life of amiodarone?
  • What dose of prednisone is a patient usually
    started on with APT?
Write a Comment
User Comments (0)
About PowerShow.com